• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Elan sale

Anonymous

Guest
Just curious as to what all you fellow Tysabri reps think will happen to us when Élan is sold. Do you think Biogen will buy them? If not, what will happen to all of us Tysabri reps?